Try our free symptom checker
Get a thorough self-assessment before your visit to the doctor.
What you should know
- Spironolactone blocks androgen receptors and works well across dose ranges.
- Finasteride lowers DHT directly and often needs higher doses for visible benefit.
- Spironolactone may cause irregular bleeding, especially at high doses.
- Finasteride may cause mild hormonal side effects that often improve over time.
- Both require long term use for sustained results.
- The best choice depends on age, hormone levels, tolerance, and pregnancy plans.
I often see women feel confused when choosing a treatment for thinning hair.
Two medications come up again and again: spironolactone and finasteride. Both affect hormones. Both can slow hair thinning. Yet they work in very different ways, and the results are not always the same.
So how do you decide between spironolactone vs finasteride for female hair loss? Let’s break it down carefully.
How do spironolactone and finasteride actually work in women?
Before comparing results, you need to understand how each drug acts inside the body. Their targets are completely different.
How Spironolactone Affects Hormones and Fluid Balance
Spironolactone blocks a hormone called aldosterone. This hormone tells your kidneys to hold onto salt and water. When spironolactone blocks it, your body releases extra sodium and water through urine. Potassium stays balanced.
That is why spironolactone lowers blood pressure and reduces swelling in conditions like heart failure, liver cirrhosis, and nephrotic syndrome.
But here is the part that matters for hair. Spironolactone also blocks androgen receptors.
Androgens are hormones like testosterone that can shrink hair follicles in female pattern hair loss. Because of this anti androgen effect, spironolactone for female hair loss helps protect follicles from hormone damage.
This makes it one of the most widely used dht blockers for women, even though it does not directly reduce DHT levels in the blood.
How finasteride lowers DHT in the scalp
Finasteride works in a more targeted way. It blocks an enzyme called 5 alpha reductase. This enzyme converts testosterone into dihydrotestosterone, also known as DHT.
DHT is a powerful hormone that drives androgenic alopecia. When finasteride blocks this enzyme, DHT levels drop by about 70% in the bloodstream.
However, DHT does not drop to zero. Hair loss slows. It does not completely stop.
If a woman stops taking finasteride, DHT levels usually return to normal within about 14 days. That means benefits disappear quickly after stopping treatment.
Finasteride for women hair loss focuses on reducing DHT in scalp tissues. It does not change salt balance or fluid levels like spironolactone does.
Which medication works better for female pattern hair loss treatment?
Now that you understand the mechanism, let’s look at real results. Does spironolactone vs finasteride women show a clear winner?
Before diving into details, it helps to know that response depends on age, hormone levels, dosage, and how long treatment continues.
How effective is spironolactone for female hair loss?
High dose spironolactone at 200 mg daily performed as well as cyproterone acetate in one open study for female pattern hair loss. That is significant because cyproterone is a strong androgen blocker.
Lower doses also show benefit. In one retrospective study of 79 women aged 21 to 79, the average dose was 100 mg daily for at least six months. Every patient either maintained or improved their Sinclair score. The average improvement was 0.65 points.
About 64% of women who used it longer than one year reached their best improvement after a full year. The benefit did not depend on menopause or birth control use.
Even low dose therapy showed promise. In women taking up to 50 mg daily for about one year, Sinclair scores improved from 2.47 to 1.81. When researchers removed patients using other therapies like minoxidil or platelet rich plasma, improvement still remained.
Side effects were mild in these lower dose groups. Some women reported lightheadedness or mild hyperkalemia. No one stopped treatment because of adverse events.
This makes spironolactone a strong option in female pattern hair loss treatment, especially for women who cannot tolerate high doses.
Does finasteride work for women with hair loss?
The answer depends heavily on dosage.
In a randomized trial of 137 postmenopausal women taking 1 mg daily for one year, finasteride showed no significant improvement compared to placebo. Hair counts even dropped slightly in both groups.
A smaller study using 1.25 mg daily showed only a 5.9% increase in density and 11.8% increase in thickness. Only 14% of women noticed visible improvement.
However, higher doses told a different story.
In postmenopausal women taking 2.5 to 5 mg daily for 18 months, all participants saw hair loss stabilize. Four out of five noticed visible regrowth.
In premenopausal women using 2.5 mg with an oral contraceptive, 62% improved in density and 78% reported better overall hair quality.
At 5 mg daily for 12 months, one study found an 18.9% increase in density and 9.4% increase in diameter. Over 80% noticed improvement.
Long term data over three years showed 82% improvement in thickness and 69% improved scalp coverage with 1.25 mg daily. Still, in women with high androgen levels, 5 mg finasteride was less effective than flutamide.
So what does this mean? Finasteride for women hair loss may require higher doses and longer treatment to see meaningful change.
What are the side effects of spironolactone vs finasteride?
No treatment is complete without discussing risks. Let’s look at spironolactone vs finasteride side effects carefully.
Side effects of spironolactone in women
At higher doses, side effects become more common.
In one study of premenopausal women taking 100 mg twice daily, 68% needed dose reduction or stopped treatment. The main issue was irregular bleeding. About 56% experienced unexpected vaginal bleeding with shortened cycles.
Other reported problems included urticaria and even scalp hair shedding in rare cases.
When the dose dropped to 50 mg twice daily, only 2 out of 10 women experienced metrorrhagia. No other side effects appeared.
This shows that bleeding risk rises with higher doses. Doctors often combine spironolactone with estrogen or progesterone to reduce cycle disruption.
Side effects of finasteride in women
In a study of 256 premenopausal women taking 5 mg daily, about 20% reported at least one side effect within three months.
These effects usually faded over time. By 36 months, only 3% still had complaints.
Reported effects included:
- Decreased libido
- Hypertrichosis
- Mastalgia
- Headache in 10% to 25%
- Menstrual irregularities
- Dizziness
- Gastrointestinal discomfort
- Dry skin
- Mild acne
Most women continued treatment because hair improvement outweighed early discomfort.
Important note: Finasteride must not be used in pregnancy. It can cause abnormalities in male fetuses. Reliable contraception is essential for premenopausal women.
How do these treatments compare side by side?
Frequently Asked Questions
Do I need a prescription for spironolactone or finasteride?
Yes. Both medications require a doctor’s prescription and proper monitoring.
Is female hair loss treatment permanent?
No. If treatment stops, hormone effects return and hair loss often resumes.
Are these the only DHT blockers for women?
No. Other anti androgen therapies exist, including flutamide and dutasteride. However, spironolactone and finasteride remain among the most commonly used.
Can spironolactone help with acne or excess hair growth?
Yes. Because it blocks androgen receptors, it also treats acne and hirsutism in women.
Was this article helpful?
References
- Burns, L. J., De Souza, B., Flynn, E., Hagigeorges, D., & Senna, M. M. (2020). Spironolactone for treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 83(1), 276–278.
- Price, V. H., Roberts, J. L., Hordinsky, M., Olsen, E. A., Savin, R., Bergfeld, W., Fiedler, V., Lucky, A., Whiting, D. A., Pappas, F., Culbertson, J., Kotey, P., Meehan, A., & Waldstreicher, J. (2000). Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Journal of the American Academy of Dermatology, 43(5 Pt 1), 768–776.
- Kim, W.-J., Song, M., Ko, H.-C., Kim, B.-S., & Kim, M.-B. (2012). Efficacy of finasteride 1.25 mg on female pattern hair loss: Pilot study. Annals of Dermatology, 24(3), 370–372.
- Iorizzo, M., Vincenzi, C., Voudouris, S., Piraccini, B. M., & Tosti, A. (2006). Finasteride treatment of female pattern hair loss. Archives of Dermatology, 142(3), 298–302.
- Helfer, E. L., Miller, J. L., & Rose, L. I. (1988). Side-effects of spironolactone therapy in the hirsute woman. The Journal of Clinical Endocrinology & Metabolism, 66(1), 208–211.
- Oliveira-Soares, R., André, M. C., & Peres-Correia, M. (2018). Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women. International Journal of Trichology, 10(1), 48–50.